+39 06 99775399 info@reithera.com
Languages
  • Italiano
  • English
The first Ebola Sudan vaccine doses to reach Uganda manufactured at ReiThera LEARN MORE
  • Home
  • About
  • R&D
  • CDMO
  • News
    • Grants
    • Press Release
    • Publications
    • Events
  • Contact
  • English
    • Italian
An ideal partner for your biotechnological journey An ideal partner for your biotechnological journey
  • Home
  • About
  • R&D
  • CDMO
  • News
    • Grants
    • Press Release
    • Publications
    • Events
  • Contact
  • English
    • Italian

Archives

Monthly Archive for: "November, 2021"
November 2021
0
By ef
In News, Press Release
Posted November 3, 2021

ReiThera Awarded Grant to Develop Next Generation Vaccines

Program funded by the Bill & Melinda Gates Foundation will use ReiThera’s GRAd platform technology to develop next generation vaccines against SARS-CoV-2 emerging variants and HIV ROME, [...]

READ MORE
0
By ef
In News, Press Release
Posted November 2, 2021

Positive Results from ReiThera’s Phase 1 Trial with COVID-19 Vaccine Candidate GRAd-COV2 Published in Science Translational Medicine

ROME, Italy, October 29th, 2021 – ReiThera Srl, a biotech company dedicated to the technology development, GMP manufacturing and clinical translation of genetic vaccines and medicinal products [...]

READ MORE
Our privacy

Privacy Policy and Cookie Law

Modello Organizzativo 231

Follow us
  • linkedin
  • facebook
  • instagram
  • twitter

ReiThera srl is a biotech company developing products based on gene delivery technologies for advanced therapies, from early development to final QP release.

© Copyright 2018 | Made with by